Development	O
of	O
delineation	O
for	O
the	O
left	B:C0226032
anterior	I:C0226032
descending	I:C0226032
coronary	I:C0226032
artery	I:C0226032
region	I:C0226032
in	O
left	O
breast	I:C4042788
cancer	I:C4042788
radiotherapy	O
:	O

Development	O
of	O
delineation	O
for	O
the	O
left	O
anterior	I:C0226032
descending	I:C0226032
coronary	I:C0226032
artery	I:C0226032
region	I:C0226032
in	O
left	B:C4042788
breast	I:C4042788
cancer	I:C4042788
radiotherapy	O
:	O

Development	O
of	O
delineation	O
for	O
the	O
left	O
anterior	I:C0226032
descending	I:C0226032
coronary	I:C0226032
artery	I:C0226032
region	I:C0226032
in	O
left	O
breast	I:C4042788
cancer	I:C4042788
radiotherapy	B:C0243005
:	O

An	O
optimized	O
organ	B:C0178784
at	O
risk	O
.	O

The	O
left	B:C0226032
anterior	I:C0226032
descending	I:C0226032
coronary	I:C0226032
artery	I:C0226032
(	O
LAD	O
)	O
and	O
diagonal	O
branches	I:C0507777
(	O
diagonal	O
branches	I:C0507777
)	O
are	O
blurred	O
on	O
computed	O
tomography	I:C0040405
(	O
computed	O
tomography	I:C0040405
)	O
.	O

The	O
left	O
anterior	I:C0226032
descending	I:C0226032
coronary	I:C0226032
artery	I:C0226032
(	O
LAD	B:C0226032
)	O
and	O
diagonal	O
branches	I:C0507777
(	O
diagonal	O
branches	I:C0507777
)	O
are	O
blurred	O
on	O
computed	O
tomography	I:C0040405
(	O
computed	O
tomography	I:C0040405
)	O
.	O

The	O
left	O
anterior	I:C0226032
descending	I:C0226032
coronary	I:C0226032
artery	I:C0226032
(	O
LAD	O
)	O
and	O
diagonal	B:C0507777
branches	I:C0507777
(	O
diagonal	O
branches	I:C0507777
)	O
are	O
blurred	O
on	O
computed	O
tomography	I:C0040405
(	O
computed	O
tomography	I:C0040405
)	O
.	O

The	O
left	O
anterior	I:C0226032
descending	I:C0226032
coronary	I:C0226032
artery	I:C0226032
(	O
LAD	O
)	O
and	O
diagonal	O
branches	I:C0507777
(	O
diagonal	B:C0507777
branches	I:C0507777
)	O
are	O
blurred	O
on	O
computed	O
tomography	I:C0040405
(	O
computed	O
tomography	I:C0040405
)	O
.	O

The	O
left	O
anterior	I:C0226032
descending	I:C0226032
coronary	I:C0226032
artery	I:C0226032
(	O
LAD	O
)	O
and	O
diagonal	O
branches	I:C0507777
(	O
diagonal	O
branches	I:C0507777
)	O
are	O
blurred	O
on	O
computed	B:C0040405
tomography	I:C0040405
(	O
computed	O
tomography	I:C0040405
)	O
.	O

The	O
left	O
anterior	I:C0226032
descending	I:C0226032
coronary	I:C0226032
artery	I:C0226032
(	O
LAD	O
)	O
and	O
diagonal	O
branches	I:C0507777
(	O
diagonal	O
branches	I:C0507777
)	O
are	O
blurred	O
on	O
computed	O
tomography	I:C0040405
(	O
computed	B:C0040405
tomography	I:C0040405
)	O
.	O

We	O
aimed	O
to	O
define	O
the	O
LAD	B:C0226032
region	I:C0226032
(	O
LAD	O
region	I:C0226032
)	O
with	O
adequate	O
inclusion	O
of	O
the	O
LAD	O
and	O
diagonal	O
branches	I:C0507777
and	O
contouring	O
consistency	O
.	O

We	O
aimed	O
to	O
define	O
the	O
LAD	O
region	I:C0226032
(	O
LAD	B:C0226032
region	I:C0226032
)	O
with	O
adequate	O
inclusion	O
of	O
the	O
LAD	O
and	O
diagonal	O
branches	I:C0507777
and	O
contouring	O
consistency	O
.	O

We	O
aimed	O
to	O
define	O
the	O
LAD	O
region	I:C0226032
(	O
LAD	O
region	I:C0226032
)	O
with	O
adequate	O
inclusion	O
of	O
the	O
LAD	B:C0226032
and	O
diagonal	O
branches	I:C0507777
and	O
contouring	O
consistency	O
.	O

We	O
aimed	O
to	O
define	O
the	O
LAD	O
region	I:C0226032
(	O
LAD	O
region	I:C0226032
)	O
with	O
adequate	O
inclusion	O
of	O
the	O
LAD	O
and	O
diagonal	B:C0507777
branches	I:C0507777
and	O
contouring	O
consistency	O
.	O

The	O
LAD	B:C0226032
region	I:C0226032
was	O
defined	O
using	O
coronary	O
CT	O
angiograms	I:C1536105
.	O

The	O
LAD	O
region	I:C0226032
was	O
defined	O
using	O
coronary	B:C0018787
CT	O
angiograms	I:C1536105
.	O

The	O
LAD	O
region	I:C0226032
was	O
defined	O
using	O
coronary	O
CT	B:C1536105
angiograms	I:C1536105
.	O

The	O
inclusion	O
ratio	O
was	O
used	O
to	O
assess	O
the	O
LAD	B:C0226032
and	O
diagonal	O
branches	I:C0507777
inclusion	O
by	O
the	O
LAD	O
region	I:C0226032
.	O

The	O
inclusion	O
ratio	O
was	O
used	O
to	O
assess	O
the	O
LAD	O
and	O
diagonal	B:C0507777
branches	I:C0507777
inclusion	O
by	O
the	O
LAD	O
region	I:C0226032
.	O

The	O
inclusion	O
ratio	O
was	O
used	O
to	O
assess	O
the	O
LAD	O
and	O
diagonal	O
branches	I:C0507777
inclusion	O
by	O
the	O
LAD	B:C0226032
region	I:C0226032
.	O

Four	O
radiation	B:C1514693
oncologists	I:C1514693
delineated	O
the	O
LAD	O
and	O
LAD	O
region	I:C0226032
,	O
using	O
contrast	O
-	I:C0040405
enhanced	I:C0040405
CT	I:C0040405
of	O
15	O
patients	O
undergoing	O
left	O
breast	I:C0222601
radiotherapy	O
.	O

Four	O
radiation	O
oncologists	I:C1514693
delineated	O
the	O
LAD	B:C0226032
and	O
LAD	O
region	I:C0226032
,	O
using	O
contrast	O
-	I:C0040405
enhanced	I:C0040405
CT	I:C0040405
of	O
15	O
patients	O
undergoing	O
left	O
breast	I:C0222601
radiotherapy	O
.	O

Four	O
radiation	O
oncologists	I:C1514693
delineated	O
the	O
LAD	O
and	O
LAD	B:C0226032
region	I:C0226032
,	O
using	O
contrast	O
-	I:C0040405
enhanced	I:C0040405
CT	I:C0040405
of	O
15	O
patients	O
undergoing	O
left	O
breast	I:C0222601
radiotherapy	O
.	O

Four	O
radiation	O
oncologists	I:C1514693
delineated	O
the	O
LAD	O
and	O
LAD	O
region	I:C0226032
,	O
using	O
contrast	B:C0040405
-	I:C0040405
enhanced	I:C0040405
CT	I:C0040405
of	O
15	O
patients	O
undergoing	O
left	O
breast	I:C0222601
radiotherapy	O
.	O

Four	O
radiation	O
oncologists	I:C1514693
delineated	O
the	O
LAD	O
and	O
LAD	O
region	I:C0226032
,	O
using	O
contrast	O
-	I:C0040405
enhanced	I:C0040405
CT	I:C0040405
of	O
15	O
patients	O
undergoing	O
left	B:C0222601
breast	I:C0222601
radiotherapy	O
.	O

Four	O
radiation	O
oncologists	I:C1514693
delineated	O
the	O
LAD	O
and	O
LAD	O
region	I:C0226032
,	O
using	O
contrast	O
-	I:C0040405
enhanced	I:C0040405
CT	I:C0040405
of	O
15	O
patients	O
undergoing	O
left	O
breast	I:C0222601
radiotherapy	B:C0243005
.	O

The	O
mean	O
dose	O
(	O
Dmean	O
)	O
and	O
maximum	O
dose	O
(	O
Dmax	O
)	O
to	O
the	O
LAD	B:C0226032
and	O
LAD	O
region	I:C0226032
were	O
calculated	O
to	O
compare	O
consistency	O
.	O

The	O
mean	O
dose	O
(	O
Dmean	O
)	O
and	O
maximum	O
dose	O
(	O
Dmax	O
)	O
to	O
the	O
LAD	O
and	O
LAD	B:C0226032
region	I:C0226032
were	O
calculated	O
to	O
compare	O
consistency	O
.	O

The	O
inclusion	O
ratio	O
of	O
the	O
LAD	B:C0226032
by	O
the	O
LAD	O
region	I:C0226032
was	O
96	O
%	O
.	O

The	O
inclusion	O
ratio	O
of	O
the	O
LAD	O
by	O
the	O
LAD	B:C0226032
region	I:C0226032
was	O
96	O
%	O
.	O

The	O
mean	O
DSI	O
,	O
JSI	O
,	O
and	O
HD	O
values	O
were	O
respectively	O
27.9	O
%	O
,	O
16.7	O
%	O
,	O
and	O
0.42	O
mm	O
for	O
the	O
LAD	B:C0226032
,	O
and	O
83.1	O
%	O
,	O
73.0	O
%	O
,	O
and	O
0.18	O
mm	O
for	O
the	O
LAD	O
region	I:C0226032
.	O

The	O
mean	O
DSI	O
,	O
JSI	O
,	O
and	O
HD	O
values	O
were	O
respectively	O
27.9	O
%	O
,	O
16.7	O
%	O
,	O
and	O
0.42	O
mm	O
for	O
the	O
LAD	O
,	O
and	O
83.1	O
%	O
,	O
73.0	O
%	O
,	O
and	O
0.18	O
mm	O
for	O
the	O
LAD	B:C0226032
region	I:C0226032
.	O

The	O
Dmean	O
between	O
the	O
LAD	B:C0226032
and	O
LAD	O
region	I:C0226032
were	O
strongly	O
correlated	O
(	O
r=0.93	O
)	O
.	O

The	O
Dmean	O
between	O
the	O
LAD	O
and	O
LAD	B:C0226032
region	I:C0226032
were	O
strongly	O
correlated	O
(	O
r=0.93	O
)	O
.	O

Delineation	O
of	O
the	O
LAD	B:C0226032
region	I:C0226032
significantly	O
improved	O
contouring	O
similarity	O
and	O
consistency	O
for	O
dose	O
reporting	O
.	O

This	O
could	O
optimize	O
dose	O
estimation	O
for	O
breast	B:C0006141
radiotherapy	O
.	O

This	O
could	O
optimize	O
dose	O
estimation	O
for	O
breast	O
radiotherapy	B:C0243005
.	O

